Malaria Consortium , London, UK.
Malaria Consortium , Kampala, Uganda.
Glob Health Action. 2020 Dec 31;13(1):1775368. doi: 10.1080/16549716.2020.1775368.
Current recommendations within integrated community case management (iCCM) programmes advise community health workers (CHWs) to refer cases of chest indrawing pneumonia to health facilities for treatment, but many children die due to delays or non-compliance with referral advice. Recent revision of World Health Organization (WHO) pneumonia guidelines and integrated management of childhood illness chart booklet recommend oral amoxicillin for treatment of lower chest indrawing (LCI) pneumonia on an outpatient basis. However, these guidelines did not recommend its use by CHWs as part of iCCM, due to insufficient evidence regarding safety. We present a protocol for a one-arm safety intervention study aimed at increasing access to treatment of pneumonia by training CHWs, locally referred to as Community Oriented Resource Persons (CORPs) in Nigeria. The primary objective was to assess if CORPs could safely and appropriately manage LCI pneumonia in 2-59 month old children, and refer children with danger signs. The primary outcomes were the proportion of children 2-59 months with LCI pneumonia who were managed appropriately by CORPs and the clinical treatment failure within 6 days of LCI pneumonia. Secondary outcomes included proportion of children with LCI followed up by CORPs on day 3; caregiver adherence to treatment for chest indrawing, acceptability and satisfaction of both CORP and caregivers on the mode of treatment, including caregiver adherence to treatment; and clinical relapse of pneumonia between day 7 to 14 among children whose signs of pneumonia disappeared by day 6. Approximately 308 children 2-59 months of age with LCI pneumonia would be needed for this safety intervention study.
当前综合社区病例管理(iCCM)计划中的建议是让社区卫生工作者(CHW)将有胸腔凹陷性肺炎的病例转介到医疗机构进行治疗,但许多儿童因延迟或不遵守转诊建议而死亡。世界卫生组织(WHO)肺炎指南和儿童疾病综合管理图表手册最近的修订版建议口服阿莫西林治疗门诊轻症胸腔凹陷性肺炎(LCI)。然而,由于安全性方面的证据不足,这些指南并未建议 CHW 将其作为 iCCM 的一部分使用。我们提出了一项单臂安全性干预研究方案,旨在通过培训 CHW(在尼日利亚被称为社区导向资源人员,CORPs)来增加治疗肺炎的机会。主要目标是评估 CORPs 是否可以安全、适当地管理 2-59 月龄儿童的 LCI 肺炎,并转介有危险征象的儿童。主要结局是由 CORPs 适当管理的 2-59 月龄有 LCI 肺炎的儿童比例和 LCI 肺炎后 6 天内临床治疗失败的比例。次要结局包括 CORPs 在第 3 天对有 LCI 肺炎的儿童进行随访的比例;照顾者对 CORP 治疗胸腔凹陷的依从性、CORP 和照顾者对治疗方式的可接受性和满意度,包括照顾者对治疗的依从性;以及第 6 天肺炎体征消失的儿童在第 7 天至第 14 天之间肺炎临床复发的情况。这项安全性干预研究需要大约 308 名 2-59 月龄有 LCI 肺炎的儿童。